Recombinant human IGF-1 alleviates dyslipidemia induced by lactational maternal dietary restriction - Scorecard - MDSpire

Recombinant human IGF-1 alleviates dyslipidemia induced by lactational maternal dietary restriction

  • By

  • Xin Liu

  • Yuanyuan Ma

  • Hong Cui

  • Qi Feng

  • June 4, 2026

  • 0 min

Share

Clinical Scorecard: Recombinant human IGF-1 mitigates dyslipidemia caused by dietary restrictions during lactation in mothers

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPreterm infants (≤ 36 weeks gestational age) and their mothers.
Care Setting

Key Highlights

  • highlight_3

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider maternal dietary interventions such as increased protein intake and omega-3 fatty acids to prevent EUGR in preterm infants.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Recombinant human IGF-1 may modulate lipid levels but does not enhance growth; monitor for potential side effects such as hypoglycemia.

        Clinical Best Practices

        • practice_1

        Related Resources & Content

        Original Source(s)

        Recombinant human IGF-1 alleviates dyslipidemia induced by lactational maternal dietary restriction

        • by Xin Liu, Yuanyuan Ma, Hong Cui, Qi Feng

        • June 4, 2026

        Related Content

        Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026

        Combination Therapy Shows Potential in Psoriasis, Obesity

        Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

        School-Based Screening Detected Undiagnosed Hypertension

        Novel program enabled large-scale blood pressure screening and identified elevated readings in community setting.